Novo Nordisk News
Latest articles and news about Novo Nordisk on AXL Media.
Latest Articles
- Amazon Pharmacy Integrates Eli Lilly’s Foundayo Weight-Loss Pill into Same-Day Kiosk Network
Published: Apr 10, 2026
Section: Science & Tech
Amazon.com announced on Thursday that its pharmacy division will stock Eli Lilly’s newly approved oral weight-loss medication, Foundayo, at automated kiosks and offer same-day deli...
- FDA Releases Landmark Draft Guidance on Validating Non-Animal Testing Methodologies for Drug Development
Published: Apr 9, 2026
Section: Health Technology
The U.S. Food and Drug Administration issued draft guidance on March 18, 2026, establishing a formal framework for validating New Approach Methodologies (NAMs) to reduce industry r...
- FDA Grants Approval for High-Dose Wegovy as Novo Nordisk Battles Eli Lilly for Weight-Loss Dominance
Published: Apr 2, 2026
Section: Science & Tech
The Food and Drug Administration has approved a 7.2-milligram dose of Novo Nordisk’s weight-loss injection, Wegovy, aimed at closing the efficacy gap with rival medications. Clinic...
- FDA Approves Eli Lilly’s Weight-Loss Pill Foundayo, Intensifying Rivalry with Novo Nordisk
Published: Apr 2, 2026
Section: Medical News
The U.S. Food and Drug Administration has granted approval to Eli Lilly’s oral weight-loss medication, orforglipron, to be marketed as Foundayo. The once-daily pill demonstrated a...
- UK Drug Watchdog Backs Novo Nordisk's Wegovy for Heart Disease Prevention via NHS
Published: Apr 1, 2026
Section: Companies & Industry
The National Institute for Health and Care Excellence (NICE) has recommended Wegovy for reducing the risk of heart attacks and strokes in obese adults. This landmark decision allow...
- Global Economic Resilience Threatened by Rising Chronic Disease Rates
Published: Mar 7, 2026
Section: Global Economy
The World Economic Forum reports that chronic conditions like obesity and diabetes are no longer merely public health issues but significant barriers to global economic competitive...
- Global Health Breakthrough: Semaglutide Production Costs Could Plunge to US$3 Monthly as Patents Expire
Published: Mar 6, 2026
Section: Medical News
A new study by researchers from Britain, South Africa, and New Zealand suggests that the manufacturing cost of semaglutide—the active ingredient in Ozempic and Wegovy—could drop to...
- Pharmaceutical Leaders Pivot Toward Oral Weight Loss Solutions in $100 Billion Market
Published: Feb 17, 2026
Section: Medical News
Global pharmaceutical giants, including Novo Nordisk and Eli Lilly, are aggressively developing oral alternatives to blockbuster injectable weight-loss drugs. These pills aim to re...